Stock Information
Johnson & Johnson (JNJ)
Ticker Symbol: JNJ
Exchange: NYSE
Sector: Pharmaceuticals
Market Cap: $486,315,868,422.00 mil
Piotroski score: 6
PE Ratio: 19.9149
EPS (TTM): 10.3607
Revenue (TTM): $37.94 M
Dividend Yield: 2.5044549%
ROE: 32.69%
Latest News
-
Best Dividend Kings: December 2025
Sun, Dec 28, 2025 6:44 AM
-
Top Midday Stories: Nvidia-Groq Licensing Deal; Target Attracts Growing Interest From Toms Capital
Fri, Dec 26, 2025 5:10 PM
-
This Cancer-Fighting Biotech Surges Into Buy Zone As Earnings Soar 131%
Fri, Dec 26, 2025 4:07 PM
-
enGene Holdings: A Potential Oncology Entrant
Fri, Dec 26, 2025 4:00 PM
-
Can J&J's Pipeline Progress in 2025 Aid Long-Term Growth?
Fri, Dec 26, 2025 1:21 PM
-
Can Amgen Sustain Its Rally In 2026
Fri, Dec 26, 2025 1:03 PM
-
PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth
Wed, Dec 24, 2025 4:20 PM
-
The Zacks Analyst Blog Highlights Invesco, Johnson & Johnson, NiSource, Bunge Global and Morgan Stanley
Wed, Dec 24, 2025 2:49 PM
-
Here’s Why Johnson & Johnson (JNJ) Surged in Q3
Wed, Dec 24, 2025 1:02 PM
-
Eli Lilly: Mr. Market Finally Woke Up, But I'm Not Out Yet (Rating Downgrade)
Wed, Dec 24, 2025 10:00 AM
Key Financials
Financial data not available
